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Background: Tissue sections of dystrophic muscle demonstrate apoptotic 
myonuclei in degenerating muscle fibers of Duchene muscle dystrophy 
(DMD) patients. The apoptosis cascade can be triggered by 2 main pathways, 
via an intrinsic, endogenous system such as the mitochondrial Bax/Bcl-2 or via 
an extrinsic system involving transmembrane receptors of the death receptor 
family Fas and Fas Ligand (FasL). 
aim of the Work: The present study is an attempt to demonstrate the levels of 
Fas and FasL and Bax/Bcl-2 in DMD pathogenesis.  
Patient and Methods: Subjects were 16 boys with DMD diagnosed clinically 
and at the molecular level versus 20 age and socioeconomic matching healthy 
boys.
results: Plasma DNA fragmentation (0.38%±0.12 vs. 0.2%±.0.1.5) and 
Fas (9.9±2.8 vs. 2±0.1, p<0.001) together with FasL mRNA expression in 
circulating lymphocytes (0.47±.09 vs. 0.24±.04, p<0.001) were significantly 
increased in DMD patients compared to controls. There was a significant 
increase in Bax mRNA relative concentration (0.19±0.07 vs. 0.05±0.01, 
p<0.00001) accompanied by a significant decrease in Bcl-2 protein in circulating 
lymphocytes (6.4±1.6 vs10±2.8, p<0.00001) both compared to controls.  
conclusion: Indicate that apoptosis and its markers determined in blood of 
DMD patients can replace the invasive technique of tissue biopsy. 
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introDUction                                         
Duchenne muscular dystrophy is an 
X-linked recessive disorder, primarily 
characterized by progressive muscle 
weakness and waisting. The disease re-
sults from the absence of dystrophin.1 
Although, the precise molecular mech-
anisms leading to muscle pathology are 
poorly understood, dystrophic muscles 
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undergo increased oxidative stress and 
altered calcium homeostasis, which 
may contribute to myofiber loss by trig-
gering both necrosis and apoptosis.2 In 
humans, DNA-fragmentation and ex-
pression of apoptosis-related proteins 
indicate that apoptosis plays a role in 
muscle degeneration and regeneration 
in muscular dystrophies.3
The apoptosis cascade can be triggered 
by 2 main pathways, via an intrinsic, 
endogenous system such as the mito-
chondrial Bax/Bcl-2 or via an extrinsic 
system Fas nd FasL involving trans-
membrane receptors of the death re-
ceptor family.4 Fas ligand is a 40-kDa 
type II membrane protein that belongs 
to the tumor necrosis factor superfam-
ily and induces apoptosis through cog-
nate interaction with its receptor Fas.5 
In contrast to Fas, which is expressed 
ubiquitously, FasL is mainly present in 
activated T lymphocytes, natural killer 
cells, and macrophages5 Activation of 
the Fas receptor through interaction 
with transmembrane FasL leads to the 
recruitment and activation of numerous 
signaling molecules, including apopto-
sis and inducing transcription factors. 
This mechanism is crucial for the suicide 
of activated T cells and macrophages.6,7 
However this mechanism has not been 
previously measured in blood of DMD 
patients.
The aim of the present study is to mea-
sure apotosis and markers of inflamma-
tory cell induced apoptosis in blood of 
DMD patients. 
PatientS anD MPethoDS                       
Patients were 16 boys with DMD di-
agnosed clinically and at the molecular 
level versus 20 age and socioeconomic 
matching healthy boys. Patients and 
controls were chosen to be, free from 
any infection and receiving no thera-
peutic treatment known to increase the 
oxidative stress. Blood samples were 
drawn after their parents’ consent.
Methods
Reverse Transcriptase - polymerase 
Chain Reaction (RT-PCR) Analysis for 
FAS-Ligand and Bax.
Total RNA was extracted from lym-
phocytes QIAGEN RNA extraction Kit 
extraction kit (QIAGEN Inc, USA). 
The RNA samples were reverse tran-
scribed using superscript reverse tran-
scriptase, using QIAGEN OneStep 
RT-PCR kit (QIAGEN Inc USA, Clini 
Lab). FasL primer sequences, forward: 
5’-CAA GTC CAA CTC AAG GTC 
CAT GCC-3’; reverse: 5’-CAG AGA 
GAG CTC AGA TAC GTT- TGAC-3’). 
Primers for β-actin were synthesized 
simultaneously as an internal reference 
for all samples (Forward: 5’-GTG GGG 
CGC CCC AGG CAC CA-3’; reverse: 
5’-CTC CTT AAT GTC ACG CAC 
GAT TTC-3’). Bax sequences8, for-
ward: 5’-CAC CAG CTC TGA- GCA 
GAT G-3’; reverse: 5’-GCG AGG CGG 
TGA- GCA CTC C-3’).  5 µl of RT 
reaction of each of the formed cDNA 
were processed for PCR. Ten µL from 
each PCR reaction product were sepa-
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rated on a 2% agarose gel then stained 
with ethidium bromide. 
The appearance of specific bands (Bax 
516 bp, β-actin 540 and FasL 345 bp) 
was evaluated under ultraviolet light 
and photographed.9
Determination of Soluble Fas was 
duplicate in duplicate plasma samples. 
Soluble Fas protein was measured us-
ing commercially available sandwich 
enzyme-linked immunosorbent assay 
(ELISA) kits.This kit uses the competi-
tive binding enzyme immunoassay for-
mat.10
DNA Fragmentation Assay:
This is done according to the method of 
Ioannou and Chen.11 In apoptosis DNA 
is broken down into fragments ranging 
from 20-200 base pairs. Separation of 
both fragmented and total DNA car-
ried out using DNA sperating kit. DNA 
fragments were gradiently separated 
from the intact DNA using polyethe-
lene glycol (5% in Ethyl ether) and 
then quantified spectrophotometrically 
using Hoechst 33258 (0.2 µg/ml) as a 
chromophore.
eliSa Bcl-2: The amounts of Bcl2 
in circulating lymphocytes were deter-
mined by a sandwich enzyme linked im-
munosorbent assay (ELISA) purchased 
from Cliniulab, using two anti-human 
BCL2 monoclonal murine antibodies. 
Statistical analysis Each experimental 
condition was performed in triplicate. 
Data are expressed as mean±SD. Com-
parisons were made by Student’s t-test. 
reSUltS                                                     
Percentage of DNA fragmentation 
per total DNA in plasma showed a 
significant increase among DMD 
patients compared to total controls 
(Mean=0.38%±0.12 vs. 0.2%±.0.1.5, 
p<0.001) as shown in (Table 1) and 
(Figure 4).
Fas in plasma, as shown in table (1) and 
(Figure 5), showed a significant increase 
among DMD patients compared to to-
tal controls (Mean 9.9±2.8 vs. 2±0.1, 
p<0.001). 
FasL mRNA relative expression    (Fig-
ure 1) as compared to β-actin  mRNA 
expression (Figure 2) in circulating lym-
phocytes showed a significant increase 
among DMD patients compared to total 
controls (Mean 0.47±.09 vs. 0.24±.04, 
p<0.001) table (1) and (Figure 6). 
Bax mRNA relative expression (Figure 
3) in circulating lymphocytes as com-
pared to compared to β-actin  mRNA 
expression figure (2) showed a sig-
nificant increase among DMD patients 
compared to controls (Mean 0.19±0.07 
vs 0.05±0.01, p<0.001), (Table 2) and 
(Figure 7).
Bcl-2 in circulating lymphocytes, as 
shown in table (2) and figure (7) showed 
a significant decrease among DMD 
patients compared to controls (Mean 
6.4±1.6 vs. 10±2.8, p<0.001).
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table 1: FasL, Fas and Percentage of DNA Fragmentation in Blood of DMD Patients Compared to 
Controls.
Percentage Dna Fragmentation Fas Fasl
DMD patients 0.38%±0.12 9.9±2.8 0.47±.09
Controls 0.2%±.0.1.5 2±0.1 0.24±.04
t 3.7 17 4.2
p p<0.001 <0.00005 <0.005
 
    M                 1                 2                3                4            5              6                7       
Fig. 1: FasL  mRNA expression in DMD patients compared to controls.
            M denotes marker, lanes 1-3 are controls and lanes 4-7 are DMD patients.
 
          M                    1               2              3               4              5            6              7       
Fig. 2: β-actin  mRNA expression in DMD patients compared to controls. 
            M denotes marker, lanes 1-3 are controls and lanes 4-7 are DMD patients.
 
         M                   1            2              3             4             5              6              7       
Fig. 3: Bax mRNA expression in DMD patients compared to controls. 
            Lanes 1-3 are controls and lanes 4-6 are DMD patients.
table 2: Bax mRNA  and Bcl-2 protein  in Blood of DMD Patients Compared to Controls.
Bcl-2 protein Bax mrna
DMD 6.4 ± 1.6 0.19 ± 0.07
controls 10 ± 2.8 0.05 ± 0.01
p< 0.001 p < 0.0000001
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Fig. 4: Percentage of DNA fragmentation per total DNA in plasma of DMD patients compared to  
            controls.
 
         M                   1            2              3             4             5              6              7       
Fig. 3: Bax mRNA expression in DMD patients compared to controls. 
            Lanes 1-3 are controls and lanes 4-6 are DMD patients.
Fig. 5: Percentage of DNA fragmentation per total Dna in plasma of DMD patients compared to  








































Indicators of Apoptosis in Duchenne Muscular Dystrophy Patients
Fig. 6 : FasL in circulating lymphocytes of DMD patients compared to controls.
































DiScUSSion                                                  
Dystrophin is thought to play a structur-
al role in providing a link between intra-
cellular actin and extracellular laminin 
via its interaction with a complex of pe-
ripheral and integral membrane proteins, 
called ‘the dystrophin–glycoprotein 
complex’ (DGC).12 Disruption of this 
linkage results in membrane instability 
and dystrophic muscle fibers are highly 
susceptible to contraction-induced inju-
ry13. Besides providing mechanical sta-
bility, several proteins of the DGC play 
a role in cell signaling.14 Altered cell 
signaling is thought to increase the sus-
ceptibility of muscle fibers to secondary 
triggers, such as functional ischemia 
and oxidative stress.15
Fas is expressed rather ubiquitously in a 
wide range of normal tissues including 
muscle cells, while FasL is expressed 
on activated T cells. Fas/Fas ligand 
interaction is an important trigger for 
apoptosis in many cell types expressing 
Fas as a surface marker.6 In the present 
study plasma Fas has been shown to be 
significantly elevated in DMD patients 
compared to controls. Increased expres-
sion of death factor Fas and decreased 
expression of the anti-apoptotic protein 
were shown to be expressed in muscles 
of DMD patients compared to con-
trols.16 Fas/FasL is involved in muscle 
cell apoptosis in at least two of the in-
flammatory myopathies, in polymyositis 
(PM), inclusion body myositis (IBM).17
The present study showed a significant 
increase in FasL among DMD patients 
compared to controls. Previous studiues 
showed that in inflammatory myopa-
thies, an infiltrate of mononuclear cells 
capable of synthesizing interferons was 
present in biopsies from DMD patients. 
The predominant cell types detected in 
both diseases were macrophages and T 
lymphocytes, these two cell types com-
prising more than 80% of the infiltrating 
mononuclear cells.18 FasL are cytotoxic 
molecules used by CD8+T lymphocytes 
and natural killer (NK) cells to induce 
apoptosis.17 Constitutively expressed 
by NK cells, perforin, granzyme B, and 
FasL expression is induced upon activa-
tion by antigen presenting cells, such 
as dendritic cells, in CD8+T lympho-
cytes.17
In the present study a significant in-
crease in plasma DNA fragmentation 
is also observed in DMD patients com-
pared to controls. Elimination of geneti-
cally damaged cells by apoptosis repre-
sent an adaptive response mechanism 
that reduce the risk of cancer and other 
genetically induced diseases from expo-
sure to radiation or other DNA damag-
ing agents.19 Muscle exercise-induced 
apoptosis is a normal regulatory process 
that serves to remove certain damaged 
cells without a pronounced inflamma-
tory response, thus ensuring optimal 
body performance.19 Accordingly, DNA 
fragmentation percentage indicates both 
apoptosis of muscle cell and circulating 
mononuclear cells were affected due 
to increased oxidative stress.20 It has 
been previously shown that apoptotic 
morphology is increased in dystrophic 
(mdx mice) muscle and in cultured 
muscle cells.21 Neutrophils recruit at a 
muscle damage sites in order to facili-
tate muscle repair through removal of 
tissue debris as well as by activation of 
satellite cells22, although somehow they 
contribute for more tissue damage by 
oxidative stress.23,24
In the present study a significant increase 
in Bax in blood mononuclear cells was 
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associated with a significant decrease 
in Bcl-2. It is a widely accepted view 
that BAX overexpression promotes cell 
death in response to apoptotic stimuli, 
whereas Bcl-2 inhibits it25,26 BAX and 
Bcl-2 can form heterodimers, and over-
expression of one antagonizes the ef-
fect of the other.27 Bax genes expresses 
a Bax, a pro-apoptotic Bcl-2 family 
member, can heterodimerize with either 
Bcl-2 or Bcl-xL to nullify their anti-
apoptotic properties.28 Increased Bax 
mRNA expression has been observed in 
aging human lymphocytes.29,30 Exercise 
loading caused an increased expression 
in Bax localization in muscular dystro-
phy animal model.31 Meaning that oxi-
dative stress due to exercise in DMD 
brings damage similar to that observed 
in aging, giving further proof to the 
present study.
It can be speculated in the present study 
that the significant increase in tissue 
Fas detected in plasma as well as circu-
lating lymphocytes’ FasL in DMD pa-
tients compared to controls contribute 
to increased apoptosis in muscle cells 
and consequently DNA fragmentation 
detected in blood. Increase in Bax and 
decreased Bcl2 in circulating mononu-
clear cells of DMD patients compared 
to controls reflects the increase of oxi-
dative stress in these patients.23,24 To 
our knowledge this is the first attempt 
to measure plasma Fas and Bax, Bcl2 
and FasL in circulating lymphocytes 
of DMD patients. Results indicate that 
apoptosis and its markers determined in 
blood of DMD patients can replace the 
invasive technique of tissue biopsy.
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